MYH9 and APOL1 are both associated with sickle cell disease nephropathy

British Journal of Haematology

Volumn 155, Issue 3, 2011, Pages 386-394

  Ashley Koch, Allison E ^a   Okocha, Emmanuel C ^a,b   Garrett, Melanie E ^a   Soldano, Karen ^a   de Castro, Laura M ^a   Jonassaint, Jude C ^a   Orringer, Eugene P ^c   Eckman, James R ^d   Telen, Marilyn J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genetic modifier; Genetics association; Nephropathy; Proteinuria; Sickle cell disease

Indexed keywords

ADULT; AGED; APOL1 GENE; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MYH9 GENE; PRIORITY JOURNAL; PROTEINURIA; SCREENING TEST; SICKLE CELL ANEMIA; SICKLE CELL DISEASE NEPHROPATHY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, SICKLE CELL; APOLIPOPROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KIDNEY DISEASES; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 80053981734     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08832.x     Document Type: Article

References (40)

1. Aslan, M., Ryan, T.M., Townes, T.M., Coward, L., Kirk, M.C., Barnes, S., Alexander, C.B., Rosenfeld, S.S. & Freeman, B.A. (2003) Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. The Journal of Biological Chemistry, 278, 4194-4204.
2. Becton, L.J., Kalpatthi, R.V., Rackoff, E., Disco, D., Orak, J.K., Jackson, S.M. & Shatat, I.F. (2010) Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatric Nephrology, 25, 1505-1511.
3. Behar, D.M., Rosset, S., Tzur, S., Selig, S., Yudkovsky, G., Bercovici, S., Kopp, J.B., Winkler, C.A., Nelson, G.W., Wasser, W.G. & Skorecki, K. (2010) African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Human Molecular Genetics, 19, 1816-1827.
4. Bostrom, M.A. & Freedman, B.I. (2010) The spectrum of MYH9-associated nephropathy. Clinical Journal of the American Society of Nephrology, 5, 1107-1113.
5. Carlson, C.S., Eberle, M.A., Rieder, M.J., Yi, Q., Kruglyak, L. & Nickerson, D.A. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. American Journal of Human Genetics, 74, 106-120.
6. De Castro, L.M., Jonassaint, J.C., Graham, F.L., Ashley-Koch, A & Telen, M.J. (2008) Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. American Journal of Hematology, 83, 19-25.
7. Derebail, V.K., Nachman, P.H., Key, N.S., Ansede, H., Falk, R.J. & Kshirsagar, A.V. (2010) High prevalence of sickle cell trait in African Americans with ESRD. Journal of the American Society of Nephrology, 21, 413-417.
8. Drenckhahn, D. & Franke, R.P. (1988) Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat, and man. Laboratory Investigation, 59, 673-682.
9. Durvasula, R.V., Petermann, A.T., Hiromura, K., Blonski, M., Pippin, J., Mundel, P., Pichler, R., Griffin, S., Couser, W.G. & Shankland, S.J. (2004) Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney International, 65, 30-39.
10. Falk, R.J., Scheinman, J., Phillips, G., Orringer, E., Johnson, A. & Jennette, J.C. (1992) Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. The New England Journal of medicine, 326, 910-915.
11. Falush, D., Stephens, M. & Pritchard, J.K. (2003) Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics, 164, 1567-1587.
12. Genovese, G., Friedman, D.J., Ross, M.D., Lecordier, L., Uzureau, P., Freedman, B.I., Bowden, D.W., Langefeld, C.D., Oleksyk, T.K., Uscinski Knob, A.L., Bernhardy, A.J., Hicks, P.J., Nelson, G.W., Vanhollebeke, B., Winkler, C.A., Kopp, J.B., Pays, E. & Pollak, M.R. (2010a) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science, 329, 841-845.
13. Genovese, G., Tonna, S.J., Knob, A.U., Appel, G.B., Katz, A., Bernhardy, A.J., Needham, A.W., Lazarus, R. & Pollak, M.R. (2010b) A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney International, 78, 698-704.
14. Guasch, A., Cua, M. & Mitch, W.E. (1996) Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney International, 49, 786-791.
15. Guasch, A., Cua, M., You, W. & Mitch, W.E. (1997) Sickle cell anemia causes a distinct pattern of glomerular dysfunction. Kidney International, 51, 826-833.
16. Guasch, A., Navarrete, J., Nass, K. & Zayas, C.F. (2006) Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. Journal of the American Society of Nephrology, 17, 2228-2235.
17. Hallan, S.I., Ritz, E., Lydersen, S., Romundstad, S., Kvenild, K. & Orth, S.R. (2009) Combining GFR and albuminuria to classify CKD improves prediction of ESRD. Journal of the American Society of Nephrology, 20, 1069-1077.
18. Kao, W.H., Klag, M.J., Meoni, L.A., Reich, D., Berthier-Schaad, Y., Li, M., Coresh, J., Patterson, N., Tandon, A., Powe, N.R., Fink, N.E., Sadler, J.H., Weir, M.R., Abboud, H.E., Adler, S.G., Divers, J., Iyengar, S.K., Freedman, B.I., Kimmel, P.L., Knowler, W.C., Kohn, O.F., Kramp, K., Leehey, D.J., Nicholas, S.B., Pahl, M.V., Schelling, J.R., Sedor, J.R., Thornley-Brown, D., Winkler, C.A., Smith, M.W. & Parekh, R.S. (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nature Genetics, 40, 1185-1192.
19. Kiberd, B.A. & Clase, C.M. (2002) Cumulative risk for developing end-stage renal disease in the US population. Journal of the American Society of Nephrology, 13, 1635-1644.
20. Kitiyakara, C., Eggers, P. & Kopp, J.B. (2004) Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. American Journal of Kidney Diseases, 44, 815-825.
21. Kopp, J.B. & Winkler, C. (2003) HIV-associated nephropathy in African Americans. Kidney International Supplement, 83, S43-S49.
22. Kopp, J.B., Smith, M.W., Nelson, G.W., Johnson, R.C., Freedman, B.I., Bowden, D.W., Oleksyk, T., McKenzie, L.M., Kajiyama, H., Ahuja, T.S., Berns, J.S., Briggs, W., Cho, M.E., Dart, R.A., Kimmel, P.L., Korbet, S.M., Michel, D.M., Mokrzycki, M.H., Schelling, J.R., Simon, E., Trachtman, H., Vlahov, D. & Winkler, C.A. (2008) MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nature Genetics, 40, 1175-1184.
23. Lake, S.L., Lyon, H., Tantisira, K., Silverman, E.K., Weiss, S.T., Laird, N.M. & Schaid, D.J. (2003) Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Human Heredity, 55, 56-65.
24. Li, J. & Ji, L. (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity, 95, 221-227.
25. Macconi, D., Ghilardi, M., Bonassi, M.E., Mohamed, E.I., Abbate, M., Colombi, F., Remuzzi, G. & Remuzzi, A. (2000) Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats. Journal of the American Society of Nephrology, 11, 477-489.
26. Nelson, G.W., Freedman, B.I., Bowden, D.W., Langefeld, C.D., An, P., Hicks, P.J., Bostrom, M.A., Johnson, R.C., Kopp, J.B. & Winkler, C.A. (2010) Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Human Molecular Genetics, 19, 1805-1815.
27. Nolan, V.G., Ma, Q., Cohen, H.T., Adewoye, A., Rybicki, A.C., Baldwin, C., Mahabir, R.N., Homan, E.P., Wyszynski, D.F., Fabry, M.E., Nagel, R.L., Farrer, L.A. & Steinberg, M.H. (2007) Estimated glomerular filtration rate in sickle cell anemia is associated with polymorphisms of bone morphogenetic protein receptor 1B. American Journal of Hematology, 82, 179-184.
28. Patterson, N., Price, A.L. & Reich, D. (2006) Population structure and eigenanalysis. PLoS Genetics, 2, e190.
29. Pham, P.T., Pham, P.C., Wilkinson, A.H. & Lew, S.Q. (2000) Renal abnormalities in sickle cell disease. Kidney International, 57, 1-8.
30. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. The New England Journal of Medicine, 330, 1639-1644.
31. Powe, N.R. (2003) To have and have not: health and health care disparities in chronic kidney disease. Kidney International, 64, 763-772.
32. Saborio, P. & Scheinman, J.I. (1999) Sickle cell nephropathy. Journal of the American Society of Nephrology, 10, 187-192.
33. Sarafidis, P.A., Riehle, J., Bogojevic, Z., Basta, E., Chugh, A. & Bakris, G.L. (2008) A comparative evaluation of various methods for microalbuminuria screening. American Journal of Nephrology, 28, 324-329.
34. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. & Poland, G.A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. American Journal of Human Genetics, 70, 425-434.
35. Schiffer, M., Bitzer, M., Roberts, I.S., Kopp, J.B., ten, D.P., Mundel, P. & Bottinger, E.P. (2001) Apoptosis in podocytes induced by TGF-beta and Smad7. The Journal of Clinical Investigation, 108, 807-816.
36. Stuart, M.J. & Nagel, R.L. (2004) Sickle-cell disease. Lancet, 364, 1343-1360.
37. Toto, R.D. (2004) Proteinuria and hypertensive nephrosclerosis in African Americans. Kidney International Supplement, 92, S102-S104.
38. Tzur, S., Rosset, S., Shemer, R., Yudkovsky, G., Selig, S., Tarekegn, A., Bekele, E., Bradman, N., Wasser, W.G., Behar, D.M. & Skorecki, K. (2010) Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Human Genetics, 128, 345-350.
39. Vinas, J.L., Hotter, G., Pi, F., Palacios, L. & Sola, A. (2007) Role of peroxynitrite on cytoskeleton alterations and apoptosis in renal ischemia-reperfusion. American Journal of Physiology. Renal Physiology, 292, F1673-F1680.
40. Zaykin, D., Zhivotovsky, L. & Weir, B.S. (1995) Exact tests for association between alleles at arbitrary numbers of loci. Genetica, 96, 169-178.